FIELD: medicine.
SUBSTANCE: invention relates to a compound presented by the general formula (V), as well as to a pharmaceutical composition based on it.
EFFECT: new compounds are obtained, which can be used for the treatment of S1P5-mediated diseases.
14 cl, 1 tbl, 61 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY | 2015 |
|
RU2767460C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR CFTR MODULATION | 2016 |
|
RU2752567C2 |
| NEW SULPHONAMIDE CARBOXAMIDE COMPOUNDS | 2018 |
|
RU2808572C2 |
| SUBSTITUTED DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2018 |
|
RU2817698C2 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| COMPOUND CAPABLE OF BONDING WITH S1P RECEPTOR AND PHARMACEUTICAL APPLICATION THEREOF | 2004 |
|
RU2390519C2 |
| PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
| NEW BIPHENYL COMPOUND OR ITS SALT | 2016 |
|
RU2726622C2 |
| NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2786722C1 |
